ID   S22AB_HUMAN             Reviewed;         550 AA.
AC   Q9NSA0; A8K426; Q53GR2; Q6ZP72; Q8NBU4;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=Solute carrier family 22 member 11;
DE   AltName: Full=Organic anion transporter 4;
GN   Name=SLC22A11; Synonyms=OAT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=10660625; DOI=10.1074/jbc.275.6.4507;
RA   Cha S.H., Sekine T., Kusuhara H., Yu E., Kim J.Y., Kim D.K.,
RA   Sugiyama Y., Kanai Y., Endou H.;
RT   "Molecular cloning and characterization of multispecific organic anion
RT   transporter 4 expressed in the placenta.";
RL   J. Biol. Chem. 275:4507-4512(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MUTAGENESIS OF HIS-47; HIS-52; HIS-83; HIS-305 AND HIS-469, FUNCTION,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=15291761; DOI=10.1042/BJ20040751;
RA   Zhou F., Pan Z., Ma J., You G.;
RT   "Mutational analysis of histidine residues in human organic anion
RT   transporter 4 (hOAT4).";
RL   Biochem. J. 384:87-92(2004).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF GLY-241 AND GLY-400.
RX   PubMed=15102942; DOI=10.1124/mol.65.5.1141;
RA   Zhou F., Tanaka K., Pan Z., Ma J., You G.;
RT   "The role of glycine residues in the function of human organic anion
RT   transporter 4.";
RL   Mol. Pharmacol. 65:1141-1147(2004).
RN   [9]
RP   MUTAGENESIS OF ASN-39; ASN-56; ASN-63 AND ASN-99, SUBCELLULAR
RP   LOCATION, AND GLYCOSYLATION.
RX   PubMed=15576633; DOI=10.1124/mol.104.007583;
RA   Zhou F., Xu W., Hong M., Pan Z., Sinko P.J., Ma J., You G.;
RT   "The role of N-linked glycosylation in protein folding, membrane
RT   targeting, and substrate binding of human organic anion transporter
RT   hOAT4.";
RL   Mol. Pharmacol. 67:868-876(2005).
CC   -!- FUNCTION: Mediates saturable uptake of estrone sulfate,
CC       dehydroepiandrosterone sulfate and related compounds.
CC       {ECO:0000269|PubMed:10660625, ECO:0000269|PubMed:15102942,
CC       ECO:0000269|PubMed:15291761}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15291761,
CC       ECO:0000269|PubMed:15576633}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15291761, ECO:0000269|PubMed:15576633}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NSA0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NSA0-2; Sequence=VSP_018319;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in placenta and kidney.
CC       {ECO:0000269|PubMed:10660625}.
CC   -!- PTM: N-glycosylated. Contains several complex-type N-glycans.
CC       {ECO:0000269|PubMed:15576633}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1)
CC       superfamily. Organic cation transporter (TC 2.A.1.19) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11483.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB026116; BAA95316.1; -; mRNA.
DR   EMBL; AK075224; BAC11483.1; ALT_INIT; mRNA.
DR   EMBL; AK129930; BAC85252.1; -; mRNA.
DR   EMBL; AK222869; BAD96589.1; -; mRNA.
DR   EMBL; AK290791; BAF83480.1; -; mRNA.
DR   EMBL; AC044790; AAK68155.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74269.1; -; Genomic_DNA.
DR   EMBL; BC034384; AAH34384.1; -; mRNA.
DR   CCDS; CCDS76425.1; -. [Q9NSA0-2]
DR   CCDS; CCDS8074.1; -. [Q9NSA0-1]
DR   RefSeq; NP_001294914.1; NM_001307985.1. [Q9NSA0-2]
DR   RefSeq; NP_060954.1; NM_018484.3. [Q9NSA0-1]
DR   UniGene; Hs.220844; -.
DR   UniGene; Hs.657603; -.
DR   ProteinModelPortal; Q9NSA0; -.
DR   BioGrid; 120967; 3.
DR   STRING; 9606.ENSP00000301891; -.
DR   BindingDB; Q9NSA0; -.
DR   ChEMBL; CHEMBL2073677; -.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB00168; Aspartame.
DR   DrugBank; DB01053; Benzylpenicillin.
DR   DrugBank; DB00887; Bumetanide.
DR   DrugBank; DB04519; Caprylic acid.
DR   DrugBank; DB00456; Cefalotin.
DR   DrugBank; DB01326; Cefamandole.
DR   DrugBank; DB01327; Cefazolin.
DR   DrugBank; DB01329; Cefoperazone.
DR   DrugBank; DB00493; Cefotaxime.
DR   DrugBank; DB01212; Ceftriaxone.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB04133; Degraded Cephaloridine.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB01160; Dinoprost Tromethamine.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB00254; Doxycycline.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00695; Furosemide.
DR   DrugBank; DB03553; Glutaric Acid.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB11560; Lesinurad.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB01017; Minocycline.
DR   DrugBank; DB01051; Novobiocin.
DR   DrugBank; DB00595; Oxytetracycline.
DR   DrugBank; DB00812; Phenylbutazone.
DR   DrugBank; DB00554; Piroxicam.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB00759; Tetracycline.
DR   DrugBank; DB00495; Zidovudine.
DR   GuidetoPHARMACOLOGY; 1030; -.
DR   TCDB; 2.A.1.19.10; the major facilitator superfamily (mfs).
DR   iPTMnet; Q9NSA0; -.
DR   PhosphoSitePlus; Q9NSA0; -.
DR   BioMuta; SLC22A11; -.
DR   DMDM; 74734337; -.
DR   PaxDb; Q9NSA0; -.
DR   PeptideAtlas; Q9NSA0; -.
DR   PRIDE; Q9NSA0; -.
DR   DNASU; 55867; -.
DR   Ensembl; ENST00000301891; ENSP00000301891; ENSG00000168065. [Q9NSA0-1]
DR   Ensembl; ENST00000377585; ENSP00000366809; ENSG00000168065. [Q9NSA0-2]
DR   GeneID; 55867; -.
DR   KEGG; hsa:55867; -.
DR   UCSC; uc001oai.4; human. [Q9NSA0-1]
DR   CTD; 55867; -.
DR   DisGeNET; 55867; -.
DR   GeneCards; SLC22A11; -.
DR   HGNC; HGNC:18120; SLC22A11.
DR   HPA; HPA026076; -.
DR   MIM; 607097; gene.
DR   neXtProt; NX_Q9NSA0; -.
DR   OpenTargets; ENSG00000168065; -.
DR   PharmGKB; PA38295; -.
DR   eggNOG; KOG0255; Eukaryota.
DR   eggNOG; COG0477; LUCA.
DR   GeneTree; ENSGT00760000118852; -.
DR   HOGENOM; HOG000234569; -.
DR   HOVERGEN; HBG108433; -.
DR   InParanoid; Q9NSA0; -.
DR   KO; K08207; -.
DR   OMA; CLVIPSQ; -.
DR   OrthoDB; EOG091G05EB; -.
DR   PhylomeDB; Q9NSA0; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-HSA-561048; Organic anion transport.
DR   ChiTaRS; SLC22A11; human.
DR   GeneWiki; SLC22A11; -.
DR   GenomeRNAi; 55867; -.
DR   PRO; PR:Q9NSA0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000168065; -.
DR   CleanEx; HS_SLC22A11; -.
DR   ExpressionAtlas; Q9NSA0; baseline and differential.
DR   Genevisible; Q9NSA0; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005452; F:inorganic anion exchanger activity; IDA:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015143; F:urate transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015711; P:organic anion transport; IDA:UniProtKB.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   GO; GO:0046415; P:urate metabolic process; IMP:BHF-UCL.
DR   GO; GO:0015747; P:urate transport; IBA:GO_Central.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion transport; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    550       Solute carrier family 22 member 11.
FT                                /FTId=PRO_0000234435.
FT   TOPO_DOM      1     10       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     11     31       Helical. {ECO:0000255}.
FT   TOPO_DOM     32    142       Extracellular. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TOPO_DOM    164    174       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    175    195       Helical. {ECO:0000255}.
FT   TOPO_DOM    196    200       Extracellular. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical. {ECO:0000255}.
FT   TOPO_DOM    222    231       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical. {ECO:0000255}.
FT   TOPO_DOM    253    256       Extracellular. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical. {ECO:0000255}.
FT   TOPO_DOM    278    346       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    347    367       Helical. {ECO:0000255}.
FT   TOPO_DOM    368    378       Extracellular. {ECO:0000255}.
FT   TRANSMEM    379    399       Helical. {ECO:0000255}.
FT   TOPO_DOM    400    402       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    403    423       Helical. {ECO:0000255}.
FT   TOPO_DOM    424    430       Extracellular. {ECO:0000255}.
FT   TRANSMEM    431    451       Helical. {ECO:0000255}.
FT   TOPO_DOM    452    463       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    464    484       Helical. {ECO:0000255}.
FT   TOPO_DOM    485    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical. {ECO:0000255}.
FT   TOPO_DOM    512    550       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     56     56       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     353    461       NFSLLISYYGLVFDLQSLGRDIFLLQALFGAVDFLGRATTA
FT                                LLLSFLGRRTIQAGSQAMAGLAILANMLVPQDLQTLRVVFA
FT                                VLGKGCFGISLTCLTIYKAELFPTPVR -> K (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_018319.
FT   VARIANT     155    155       V -> G (in dbSNP:rs12785832).
FT                                /FTId=VAR_053962.
FT   MUTAGEN      39     39       N->Q: No visible effect on N-
FT                                glycosylation. Loss of N-glycosylation
FT                                and of cell surface location; when
FT                                associated with Q-56; Q-63 and Q-99.
FT                                {ECO:0000269|PubMed:15576633}.
FT   MUTAGEN      47     47       H->A: Reduced cell surface expression and
FT                                estrone sulfate transport. Reduced cell
FT                                surface expression and estrone sulfate
FT                                transport; when associated with A-52; A-
FT                                83; A-305 and A-469.
FT                                {ECO:0000269|PubMed:15291761}.
FT   MUTAGEN      52     52       H->A: Slightly reduced estrone sulfate
FT                                transport. Reduced cell surface
FT                                expression and estrone sulfate transport;
FT                                when associated with A-47; A-83; A-305
FT                                and A-469. {ECO:0000269|PubMed:15291761}.
FT   MUTAGEN      56     56       N->Q: No visible effect on N-
FT                                glycosylation. Loss of N-glycosylation
FT                                and of cell surface expression; when
FT                                associated with Q-39; Q-63 and Q-99.
FT                                {ECO:0000269|PubMed:15576633}.
FT   MUTAGEN      63     63       N->Q: No visible effect on N-
FT                                glycosylation. Loss of N-glycosylation
FT                                and of cell surface expression; when
FT                                associated with Q-39; Q-56 and Q-99.
FT                                {ECO:0000269|PubMed:15576633}.
FT   MUTAGEN      83     83       H->A: Reduced cell surface expression and
FT                                estrone sulfate transport; when
FT                                associated with A-47; A-52; A-305 and A-
FT                                469. {ECO:0000269|PubMed:15291761}.
FT   MUTAGEN      99     99       N->Q: No visible effect on N-
FT                                glycosylation. Loss of N-glycosylation
FT                                and of cell surface expression; when
FT                                associated with Q-39; Q-56 and Q-63.
FT                                {ECO:0000269|PubMed:15576633}.
FT   MUTAGEN     241    241       G->L,S,V: Strongly reduced cell surface
FT                                expression and estrone sulfate transport.
FT                                {ECO:0000269|PubMed:15102942}.
FT   MUTAGEN     305    305       H->A: Reduced cell surface expression and
FT                                estrone sulfate transport; when
FT                                associated with A-47; A-52; A-83 and A-
FT                                469. {ECO:0000269|PubMed:15291761}.
FT   MUTAGEN     400    400       G->L,S,V: Strongly reduced cell surface
FT                                expression and estrone sulfate transport.
FT                                {ECO:0000269|PubMed:15102942}.
FT   MUTAGEN     469    469       H->A: Slightly reduced estrone sulfate
FT                                transport. Reduced cell surface
FT                                expression and estrone sulfate transport;
FT                                when associated with A-47; A-52; A-83 and
FT                                A-305. {ECO:0000269|PubMed:15291761}.
FT   CONFLICT    180    180       L -> S (in Ref. 3; BAD96589).
FT                                {ECO:0000305}.
FT   CONFLICT    376    376       L -> R (in Ref. 2; BAC85252).
FT                                {ECO:0000305}.
SQ   SEQUENCE   550 AA;  59972 MW;  233BE6C4A520E58A CRC64;
     MAFSKLLEQA GGVGLFQTLQ VLTFILPCLM IPSQMLLENF SAAIPGHRCW THMLDNGSAV
     STNMTPKALL TISIPPGPNQ GPHQCRRFRQ PQWQLLDPNA TATSWSEADT EPCVDGWVYD
     RSVFTSTIVA KWDLVCSSQG LKPLSQSIFM SGILVGSFIW GLLSYRFGRK PMLSWCCLQL
     AVAGTSTIFA PTFVIYCGLR FVAAFGMAGI FLSSLTLMVE WTTTSRRAVT MTVVGCAFSA
     GQAALGGLAF ALRDWRTLQL AASVPFFAIS LISWWLPESA RWLIIKGKPD QALQELRKVA
     RINGHKEAKN LTIEVLMSSV KEEVASAKEP RSVLDLFCVP VLRWRSCAML VVNFSLLISY
     YGLVFDLQSL GRDIFLLQAL FGAVDFLGRA TTALLLSFLG RRTIQAGSQA MAGLAILANM
     LVPQDLQTLR VVFAVLGKGC FGISLTCLTI YKAELFPTPV RMTADGILHT VGRLGAMMGP
     LILMSRQALP LLPPLLYGVI SIASSLVVLF FLPETQGLPL PDTIQDLESQ KSTAAQGNRQ
     EAVTVESTSL
//
